New York Attorney General Eric Schneiderman said Wednesday his office has filed a lawsuit against a U.S. unit of Swiss pharmaceutical giant Novartis AG regarding an alleged kickback scheme related to its iron-reduction drug, Exjade.. The lawsuit, unsealed by Manhattan U.S. District Court Judge Colleen McMahon, alleges that Novartis Pharmaceuticals Corp. paid kickbacks to pharmacy company BioScrip Inc., Elmsford, N.Y., to boost sales of Exjade.